2 Sources
2 Sources
[1]
Chinese insurance broker Yuanbao files for US IPO amid reviving investor appetite
Sept 17 (Reuters) - Chinese insurance broker Yuanbao on Tuesday filed for an initial public offering in the United States, signaling a broader recovery in investor appetite for new listings. WHY IT'S IMPORTANT IPOs in the U.S. are experiencing a reasonably stronger year after a prolonged dry spell as more companies test the market, encouraged by the strong performance of high-profile listings like Reddit (RDDT.N), opens new tab, alongside a rally in equities. Advertisement · Scroll to continue But, the number of IPOs by China-based companies in the U.S. has come down significantly in the last several years, after Beijing clamped down on offshore capital raising in 2021. EV maker Zeekr's (ZK.N), opens new tab debut on the New York Stock Exchange earlier this year was the first big listing by a Chinese company in the U.S. since ride-hailing giant Didi Global was forced to delist its shares in late 2021 following a backlash from Chinese regulators. Advertisement · Scroll to continue CONTEXT Yuanbao is an online insurance distributor in China, that uses data and artificial intelligence to provide customizable insurance plans to its customers. The company is the largest independent insurance distributor in China's personal life and accident and health (A&H) insurance market in terms of first-year premiums in 2023, the company said in its IPO filing. Goldman Sachs, Citigroup and CICC are the lead underwriters for the offering. BY THE NUMBERS Yuanbao's full-year revenue rose to 2.05 billion Chinese yuan ($289.02 million) in 2023, compared to 850.3 million Chinese yuan a year earlier, the company said. The company's first-year premiums more than doubled to 17.6 billion Chinese yuan ($2.48 billion) in 2023, from 8.5 billion Chinese yuan in the year-ago period. WHAT'S NEXT Yuanbao, which did not reveal the terms of its offering, is planning to list American depositary shares (ADS) on the Nasdaq under the ticker symbol "YB". ($1 = 7.0930 Chinese yuan renminbi) Reporting by Jaiveer Singh Shekhawat in Bengaluru; Editing by Tasim Zahid Our Standards: The Thomson Reuters Trust Principles., opens new tab
[2]
Chinese insurance broker Yuanbao files for US IPO amid reviving investor appetite
(Reuters) - Chinese insurance broker Yuanbao on Tuesday filed for an initial public offering in the United States, signaling a broader recovery in investor appetite for new listings. WHY IT'S IMPORTANT IPOs in the U.S. are experiencing a reasonably stronger year after a prolonged dry spell as more companies test the market, encouraged by the strong performance of high-profile listings like Reddit, alongside a rally in equities. But, the number of IPOs by China-based companies in the U.S. has come down significantly in the last several years, after Beijing clamped down on offshore capital raising in 2021. EV maker Zeekr's debut on the New York Stock Exchange earlier this year was the first big listing by a Chinese company in the U.S. since ride-hailing giant Didi Global was forced to delist its shares in late 2021 following a backlash from Chinese regulators. CONTEXT Yuanbao is an online insurance distributor in China, that uses data and artificial intelligence to provide customizable insurance plans to its customers. The company is the largest independent insurance distributor in China's personal life and accident and health (A&H) insurance market in terms of first-year premiums in 2023, the company said in its IPO filing. Goldman Sachs, Citigroup and CICC are the lead underwriters for the offering. BY THE NUMBERS Yuanbao's full-year revenue rose to 2.05 billion Chinese yuan ($289.02 million) in 2023, compared to 850.3 million Chinese yuan a year earlier, the company said. The company's first-year premiums more than doubled to 17.6 billion Chinese yuan ($2.48 billion) in 2023, from 8.5 billion Chinese yuan in the year-ago period. WHAT'S NEXT Yuanbao, which did not reveal the terms of its offering, is planning to list American depositary shares (ADS) on the Nasdaq under the ticker symbol "YB". (Reporting by Jaiveer Singh Shekhawat in Bengaluru; Editing by Tasim Zahid)
Share
Share
Copy Link
Yuanbao, a Chinese insurance broker, has filed for an initial public offering (IPO) in the United States, signaling a potential revival of Chinese listings in the US market. This move comes as investor interest in Chinese stocks appears to be rekindling.

Yuanbao, a prominent Chinese insurance broker, has taken a significant step towards expanding its global presence by filing for an initial public offering (IPO) in the United States
1
. This move marks a potential turning point in the landscape of Chinese companies listing on US exchanges, which has been relatively quiet in recent years due to regulatory concerns and geopolitical tensions.The decision by Yuanbao to pursue a US listing comes at a time when there are signs of reviving investor appetite for Chinese stocks
2
. This renewed interest is particularly noteworthy given the recent challenges faced by Chinese companies in accessing US capital markets. The timing of Yuanbao's filing suggests a strategic move to capitalize on improving market sentiment and potentially pave the way for other Chinese firms considering similar actions.Yuanbao operates as an online insurance brokerage platform, leveraging technology to connect consumers with insurance products. The company's business model focuses on providing a wide range of insurance options to Chinese consumers, tapping into the growing demand for insurance services in one of the world's largest markets
1
.The filing by Yuanbao comes against the backdrop of ongoing regulatory scrutiny of Chinese companies listing in the US. In recent years, concerns over accounting practices and data security have led to increased oversight and stricter requirements for foreign issuers. Yuanbao's move to list in the US suggests a willingness to comply with these enhanced regulatory standards, potentially setting a precedent for other Chinese firms
2
.Related Stories
Yuanbao's IPO filing could be seen as a positive signal for US-China financial relations, which have been strained in recent years. A successful listing might encourage other Chinese companies to consider US markets, potentially leading to increased cross-border investment flows. This development could contribute to a thawing of tensions in the financial sector between the two economic powerhouses
1
.The market's response to Yuanbao's filing will be closely watched by investors, analysts, and other Chinese companies considering similar moves. A positive reception could signal a broader shift in investor sentiment towards Chinese stocks and potentially open the door for more listings from the region. Conversely, any challenges or skepticism faced by Yuanbao could have implications for future Chinese IPOs in the US market
2
.Summarized by
Navi
18 Oct 2024•Business and Economy

21 Feb 2025•Business and Economy

15 Nov 2024•Business and Economy

1
Technology

2
Technology

3
Technology
